enquiry@dsij.in |+91 9240904920
SENSEX-307.24
76,957.27-0.4%

Bharat Electronics order pipeline and indigenisation underpin defence earnings visibility

Bharat Electronics Ltd.

Broker Recommendation:

BUY

Broker: ICICI Securities Limited / ICICI Direct Research

28 Jul 2026

Sector: Capital Goods

Reco. Price

₹394

CMP

₹414

Target

₹530

Upside

34.52%

Investment View and Valuation

In its July 28, 2026 result update, ICICI Direct Research retains its BUY view on Bharat Electronics (BEL), citing strong earnings visibility from a large and diversified order backlog, a robust defence-programme pipeline and improving execution supported by greater indigenisation.

ICICI Direct values BEL at 45 times FY28E EPS to derive a target price of Rs 530.

Q1FY27 Financial Performance

BEL reported Q1FY27 consolidated revenue of Rs 5,547 crore, up 25.0 per cent year on year but down 45.7 per cent sequentially, driven by healthy execution across key defence-electronics programmes.

EBITDA rose 12.1 per cent year on year to Rs 1,388 crore, while the EBITDA margin declined 286 basis points year on year to 25.0 per cent because of an adverse product mix. PAT increased 8.8 per cent year on year to Rs 1,055 crore.

Management stated that quarterly margins are mainly influenced by product mix rather than input-cost inflation and expects margins to normalise in subsequent quarters.

Order Backlog and Execution

BEL ended Q1FY27 with an order backlog of Rs 72,258 crore, equivalent to about 2.6 times FY26 revenue. The backlog is diversified broadly equally across the Army, Navy and Air Force.

Major programmes include Electronic Fuses, LRSAM, LCA Mk1/Mk1A LRUs, BMP-2 Upgrade, Ashwini Radar and electronic-warfare systems. These programmes account for about Rs 20,000 crore of the backlog.

Execution during the quarter was healthy across LRSAM, MPR Arudhra, LCA LRUs, BMP-2 Upgrade, Himshakti, Akash-T, electronic-warfare systems, fuses and receivers.

FY27E Guidance and Defence Programme Pipeline

Management maintained its FY27E guidance as follows:

  • Revenue growth of above 15 per cent.
  • EBITDA margin of above 28 per cent.
  • Order inflows of above Rs 55,000 crore, including QRSAM.
  • Capital expenditure of above Rs 1,200 crore.
  • Research and development investment of above Rs 2,200 crore.

Lower Q1FY27 order inflows reflected timing, according to management, because FY26 inflows exceeded internal expectations at more than Rs 30,000 crore versus approximately Rs 25,000 crore planned.

Management expects QRSAM to receive CCS approval by September 2026. Potential FY27 awards also include Shatrughat and Samaghat, HAMMER, Shakti Phase-IV and at least one of NGC or P-75I.

Existing backlog and regular base orders are expected to support FY27-FY28 execution. Large platform orders such as QRSAM, NGC and P-75I are likely to contribute materially only after development and qualification.

Technology, Indigenisation and Export Opportunities

ICICI Direct highlights BEL's technology leadership and rising indigenous content as supports for sustainable growth and margins. Indigenous content is currently about 80-85 per cent and is targeted to reach about 90 per cent in DRDO programmes.

BEL is expanding capabilities in counter-drone systems, directed-energy weapons, artificial-intelligence-enabled defence electronics and next-generation communication technologies. The company aims to indigenise imported modules and sub-systems, excluding semiconductor components, over the next five years.

Management cited a US dollar 465 million export pipeline, a FY27 export target of US dollar 300 million and a medium-term aim for exports to reach about 10 per cent of revenue.

Financial Forecasts

Particulars FY27E FY28E
Revenue Rs 32,304 crore Rs 38,070 crore
EBITDA Rs 9,304 crore Rs 11,135 crore
PAT Rs 7,045 crore Rs 8,546 crore
EPS Not specified Rs 11.7

Key Risks

  • Dependence on government contracts.
  • High working-capital requirements.
  • Availability of key raw materials and components.
View / Download Original Research Report

Disclaimer: This is a summary of a research report published by the broker/research house identified above. The views, recommendations, target prices and estimates are those of the respective broker and do not represent DSIJ investment advice. The summary may be AI-assisted, hence please refer to the original report for complete details, disclosures and risks.